ZHONGHUA YANGSHENG BAOJIAN ›› 2022, Vol. 40 ›› Issue (7): 60-63.
Previous Articles Next Articles
Published:
2022-05-16
CLC Number:
[1] 黄燕华. 冠心病患者服阿司匹林致上消化道出血的风险分析[J].医学食疗与健康,2020,18(13):89-90. [2] 刘钦伟,龙利.替格瑞洛联合阿司匹林对冠心病患者血清MPO水平、APTT及上消化道出血发生率的影响[J].国际医药卫生导报,2019,25(17):2891-2895. [3] 戴惠钦,洪雷,杜巧媚,等.抗血小板药物治疗冠心病病人中应用CRUSADE评分对消化系统出血风险的评估作用[J].蚌埠医学院学报,2020,45(3):345-347. [4] 雷振民,汪希.冠心病患者双联抗血小板治疗中上消化道出血影响因素分析[J].实用临床医药杂志,2020,24(14):112-114. [5] 郝雁翎,蔡晓晶.护患沟通技巧在奥曲肽治疗上消化道出血护理中及对患者不良反应发生的影响[J].检验医学与临床,2020,17(15):2240-2242. [6] 中华医学会心血管病学分会、中华心血管病杂志编辑委员会.冠心病诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. [7] 许国铭,李兆申.上消化道内镜学[M].上海:上海科学技术出版社,2003. [8] 王彦婷. 护理干预措施应用于冠心病服用肠溶阿司匹林致上消化道出血患者的临床效果观察[J].现代消化及介入诊疗,2016,21(5):795-796. [9] 王飞宇,赵小红,牟小引.综合护理干预在阿司匹林致冠心病患者上消化道出血治疗中的应用价值[J].现代消化及介入诊疗,2017, 22(6):895-897. [10] 岳林君,卫迎迎,樊江波,等.阳离子碳点在癌症诊断和基因治疗一体化中的研究进展[J].新型炭材料,2021,36(2):373-389. |
[1] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 16-19. |
[2] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 93-96. |
[3] | YI Hai-ling. The Application Effect of A New Health Education Model in High-quality Nursing of Thoracic Surgery [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 96-99. |
[4] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 99-102. |
[5] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 102-105. |
[6] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 105-108. |
[7] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 109-111. |
[8] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 112-114. |
[9] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 115-117. |
[10] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 118-121. |
[11] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 121-124. |
[12] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 124-127. |
[13] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 131-134. |
[14] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 134-137. |
[15] | . [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(10): 137-140. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||